Skip to main content
Cyrus DeSouza, MD, Endocrinology, Omaha, NE

CyrusVDeSouzaMD

Endocrinology Omaha, NE

Diabetes, Lipid Metabolism

Associate Professor, Internal Medicine, University of Nebraska Medical Center College of Medicine

Dr. DeSouza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. DeSouza's full profile

Already have an account?

  • Office

    988095 Nebraska Medical Ctr
    Omaha, NE 68198
    Phone+1 402-559-9800
    Fax+1 402-559-9840

Education & Training

  • Tulane University
    Tulane UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002
  • St Barnabas Hospital
    St Barnabas HospitalResidency, Internal Medicine, 1997 - 2000
  • St. John's Medical College
    St. John's Medical CollegeClass of 1996

Certifications & Licensure

  • NE State Medical License
    NE State Medical License 2002 - 2026
  • TX State Medical License
    TX State Medical License 2009 - 2024
  • LA State Medical License
    LA State Medical License 2000 - 2004
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Behavioral Therapy with in-Clinic or Telephone Group Visits vs in-Clinic Individual Visits on Weight Loss Among Patients with Obesity in Rural Clinical Practice  
    Cyrus Desouza, Alexandra R Brown, Leslie Eiland, JAMA
  • A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients with Type 2 Diabetes Suboptimally Controlled on Diet and Exe...  
    Ildiko Lingvay, Cyrus V Desouza, Diabetes Care

Lectures

  • Achieving Glycaemic Control Without Weight Gain, Hypoglycaemia, or Gastrointestinal Adverse Events in Type 2 Diabetes in the SUSTAIN Clinical Trial Programme 
    Omaha, NE - 6/14/2014

Professional Memberships